Structure-activity relationship study on anti-HIV 6-desfluoroquinolones

Journal of Medicinal Chemistry

Volumn 51, Issue 17, 2008, Pages 5454-5458

  Tabarrini, Oriana ^a   Massari, Serena ^a   Daelemans, Dirk ^b   Stevens, Miguel ^b   Manfroni, Giuseppe ^a   Sabatini, Stefano ^a   Balzarini, Jan ^b   Cecchetti, Violetta ^a   Pannecouque, Christophe ^b   Fravolini, Arnaldo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 4 OXO 7 [4 [3 (TRIFLUOROMETHYL)PHENYL] 1 PIPERAZINYL] 1,4 DIHYDRO 3 QUINOLINECARBOXYLIC ACID; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HM 12; HM 13; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOTOXICITY; DRUG POTENCY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; STRUCTURE ACTIVITY RELATION; VIRUS GENE;

ANTI-HIV AGENTS; CELLS, CULTURED; HIV INFECTIONS; HIV-1; HUMANS; QUINOLINES; QUINOLONES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 51849133134     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm701585h     Document Type: Article

References (24)

1. Hirsch, M. S.; Conway, B.; D'Aquila, R. T.; Johnson, V. A.; Brun-Vezinet, F.; Clotet, B.; Demeter, L. M.; Hammer, S. M.; Jacobsen, D. M.; Richman, D. D. Antiretroviral Drug Resistance Testing in Adult HIV-infection. J. Am. Med. Assoc. 2000, 279, 1984-1991.
2. Marcello, A. Latency: the Hidden HIV-1 Challenge. Retrovirology 2006, 3, 7.
3. + T cells in Viremic versus Aviremic HIV-infected Individuals. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 1908-1913.
4. McElrath, M. J.; Pruett, J. E.; Cohn, Z. A. Mononuclear Phagocytes of Blood and Bone Marrow: Comparative Roles as Viral Reservoirs in Human Immunodeficiency Virus Type 1 Infections. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 675-679.
5. Daelemans, D.; Vandamme, A. M.; De Clercq, E. Human Immunodeficiency Virus Gene Regulation as Target for Antiviral Chemotherapy. Antivir. Chem. Chemother. 1999, 10, 1-10.
6. For recent review see:(a) Baba, M. Recent Status of HIV-1 Gene Expression Inhibitors. Antivir. Res. 2006, 71, 301-306.
7. Stevens, M.; De Clercq, E.; Balzarini, J. The Regulation of HIV-1 Transcription: Molecular Targets for Chemotherapeutic Intervention. Med. Res. Rev. 2006, 5, 595-625.
8. Cecchetti, V.; Parolin, C.; Moro, S.; Pecere, T.; Filipponi, E.; Calistri, A.; Tabarrini, O.; Gatto, B.; Palumbo, M.; Fravolini, A.; Palù, G. 6-Aminoquinolones as New Potential Anti-HIV Agents. J. Med. Chem. 2000, 3, 3799-3802.
9. Tabarrini, O.; Stevens, M.; Cecchetti, V.; Sabatini, S.; Dell'Uomo, M.; Manfroni, G.; Palumbo, M.; Pannecouque, C.; De Clercq, E.; Fravolini, A. Structure Modifications of 6-Aminoquinolones with Potent anti-HIV Activity. J. Med. Chem. 2004, 47, 5567-5578.
10. Stevens, M.; Balzarini, J.; Tabarrini, O.; Andrei, G.; Snoeck, R.; Cecchetti, V.; Fravolini, A.; De Clercq, E.; Pannecouque, C. Cell-Dependent Interference of a Series of New 6-Aminoquinolone Derivatives with Viral (HIV/CMV) Transactivation. J. Antimicrob. Chemother. 2005, 56, 847-855.
11. Sato, M.; Motomura, T.; Aramaki, H.; Matsuda, T.; Yamashita, M.; Ito, Y.; Kawakami, H.; Matsuzaki, Y.; Watanabe, W.; Yamataka, K.; Ikeda, S.; Kodama, E.; Matsuoka, M.; Shinkai, H. Novel HIV-1 Integrase Inhibitors Derived from Quinolone Antibiotics. J. Med. Chem. 2006, 49, 1506-1508.
12. Daelemans, D.; Lu, R.; De Clercq, E.; Engelman, A. Characterization of a Replication-Competent, Integrase-defective Human Immunodeficiency Virus (HIV)/Simian Virus 40 Chimera as a Powerful Tool for the Discovery and Validation of HIV Integrase Inhibitors. J. Virol. 2007, 81, 4381-4385.
13. Schenone, P.; Sansebastiano, L; Mosti, L. Reaction of 2-Dimethylaminomethylene-1,3-diones with Dinucleophiles. VIII Synthesis of Ethyl and Methyl 2,4-disubstituited 5-pyrimidinecarboxylates-[1]. J. Heterocycl. Chem. 1990, 27, 295-305.
14. Barton, N.; Crowther, A. F.; Hepworth, W.; Richardson, D. N.; Driver, G. W. Quinolones and Therapeutic Compositions Containing Them. UK Patent GB 830832, 1960.
15. Petersen, U.; Grohe, K.; Kuck, K. H. Quinolonecarboxylic Acid Derivatives and Their Use as Bactericidal Agents. German Patent DE 3308908, 1985.
16. Koga, H.; Itoh, A.; Murayama, S.; Suzue, S.; Irikura, T. Structure-Activity Relationships of Antibacterial 6,7- and 7,8-Disubstituted 1-Alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic Acids. J. Med. Chem. 1980, 23, 1358-1363.
17. Baba, M.; Okamoto, M.; Kawamura, M.; Makino, M.; Higashida, T.; Takashi, T.; Kimura, Y.; Ikeuchi, T.; Tetsuka, T.; Okamoto, T. Inhibition of Human Immunodeficiency Virus Type 1 Replication and Cytokine Production by Fluoroquinolone Derivatives. Mol. Pharmacol. 1998, 53, 1097-1103.
18. Mitscher, L. A.; Devasthale, P.; Zavod, R. Structure-Activity Relationships In Quinolone Antimicrobial Agents, 2nd ed.; Hooper, D. C., Wolfson, J. S., Eds.; American Society for Microbiology: Washington, D.C., 1998; pp3-51.
19. Richter, S.; Parolin, C.; Palumbo, M.; Palù, G. Antiviral Properties of Quinolone-based Drugs. Curr. Drug Targets - Infect. Disord. 2004, 4, 111-116.
20. (a) For a discussion of the tautomer equilibrium in the 4-hydroxyquinoline heterocycle, see:De la Cruz, A.; Elguero, J.; Goya, P.; Martínez, A. Tautomerism and Acidity in 4-Quinolone-3-Carboxylic Acid Derivatives. Tetrahedron 1992, 48, 6135-6150.
21. Palumbo, M.; Gatto, B.; Zagotto, G.; Palù, G. On the Mechanism action of Quinolone Drugs. Trends Microbiol. 1993, 1, 232-235.
22. Fluorimetric tritation experiments for 11 were performed in similar conditions to that reported for compound 1 and ciprofloxacin in ref 23.
23. Richter, S.; Gatto, B.; Tabarrini, O.; Fravolini, A.; Palumbo, M. Antiviral 6-Aminoquinolones: Molecular Basis for Potency and Selectivity. Bioorg. Med. Chem. Lett. 2005, 15, 4247-4251.
24. Stevens, M.; Pollicita, M.; Pannecouque, C.; Verbeken, E.; Tabarrini, O.; Cecchetti, V.; Acquaro, S.; Perno, C. F.; Fravolini, A.; Schols, D.; De Clercq, E; Balzarini, J. A Novel in Vivo Model for the Study of HIV-1 Transcription Inhibitors: Evaluation of New 6-Desfluoroquinolone Derivatives (6-DFQs). Antimicrob. Agents Chemother. 2007, 4, 1407-1413.